Context Soil-Transmitted Helminth (STH) infections are among the neglected tropical diseases with the highest prevalence and incidence in children aged 6 to 15 years. Appropriate health and nutrition interventions are necessary to prevent long-term adverse effects of parasitic infection. One example is the biannual school-based mass drug administration by the Department of Health in partnership with the Department of Education, as recommended by the World Health Organization.

Objectives The general objective of the study is to determine the effectiveness of albendazole in reducing STH infection among school-aged children in 5th grade. Specifically, the study aims to identify the most common type of STH infection among the respondents, and to calculate the cure rate (CR) and egg reduction rate (ERR) overall and for each helminth species.

Study Design Descriptive and comparative

Study Setting Stool samples from the students were collected at a local public elementary school and processed in the Microbiology Laboratory of the Cebu Institute of Medicine.

Participants All grade five students were invited to participate, with a final sample size of 188 respondents.

Maneuver A total of four stool samples were collected from each participant: two before deworming (July 16-26, 2019) and two more 14 to 21 days after the first deworming cycle. All samples were analyzed using the Kato-Katz method. McNemars test was used as the statistical tool.

Main Outcome Measures Percentage and intensity of STH infection, cure rate (CR), egg reduction rate (ERR), and effectiveness of intervention

Results Of the 49 respondents, 10 (20.41%) were positive for STH at baseline. Single infection with Ascaris lumbricoides (12.24%) was most frequent, followed by co-infection with A. lumbricoides and Trichuris trichiura (4.08%), and single infection with T. trichiura (2.04%). Albendazole yielded a 100% CR and ERR for A. lumbricoides. CR and ERR for T. trichiura were 33.33% and 51.25%, respectively.

Implications The drug is effective in reducing viable egg count in infected patients but is not sufficient to cure patients with T. trichiura infection.

Conclusion A single 400 mg dose of Albendazole was effective against ascariasis. It was also effective against trichuriasis in terms of egg reduction, but not in terms of cure rate.

Recommendations The DOH protocol should be re-evaluated regarding the use of a triple dose of albendazole instead of a single dose to address T. trichiura infection. Follow-up surveillance is recommended to monitor the effectiveness of the deworming program. Educating stakeholders to increase awareness and participation is also advised. Future researchers should investigate possible risk factors contributing to STH infection to inform further preventive action.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Cebu City Health Department, in collaboration with the Institutional Review Board of the Cebu Institute of Medicine, gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript